90 related articles for article (PubMed ID: 9588212)
1. A putative tumor suppressor, TSG101, acts as a transcriptional suppressor through its coiled-coil domain.
Watanabe M; Yanagi Y; Masuhiro Y; Yano T; Yoshikawa H; Yanagisawa J; Kato S
Biochem Biophys Res Commun; 1998 Apr; 245(3):900-5. PubMed ID: 9588212
[TBL] [Abstract][Full Text] [Related]
2. Physical and functional interactions between Daxx and TSG101.
Muromoto R; Sugiyama K; Yamamoto T; Oritani K; Shimoda K; Matsuda T
Biochem Biophys Res Commun; 2004 Apr; 316(3):827-33. PubMed ID: 15033475
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activators direct histone acetyltransferase complexes to nucleosomes.
Utley RT; Ikeda K; Grant PA; Côté J; Steger DJ; Eberharter A; John S; Workman JL
Nature; 1998 Jul; 394(6692):498-502. PubMed ID: 9697775
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.
Demirov DG; Ono A; Orenstein JM; Freed EO
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):955-60. PubMed ID: 11805336
[TBL] [Abstract][Full Text] [Related]
5. Expression of a new isoform of the tumor susceptibility TSG101 protein lacking a leucine zipper domain in Burkitt lymphoma cell lines.
Ferrer M; López-Borges S; Lazo PA
Oncogene; 1999 Apr; 18(13):2253-9. PubMed ID: 10327071
[TBL] [Abstract][Full Text] [Related]
6. [The action of TSG101 on HIV-1 budding and related inhibitors].
Chen HF; Liu XY
Yao Xue Xue Bao; 2008 Dec; 43(12):1165-70. PubMed ID: 19244744
[TBL] [Abstract][Full Text] [Related]
7. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of chromatin remodelling factors during gene activation via the glucocorticoid receptor N-terminal domain.
Wallberg AE; Flinn EM; Gustafsson JA; Wright AP
Biochem Soc Trans; 2000; 28(4):410-4. PubMed ID: 10961930
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptors, their coactivators and modulation of transcription.
Manteuffel-Cymborowska M
Acta Biochim Pol; 1999; 46(1):77-89. PubMed ID: 10453983
[TBL] [Abstract][Full Text] [Related]
10. Biological activity of mammalian transcriptional repressors.
Thiel G; Lietz M; Bach K; Guethlein L; Cibelli G
Biol Chem; 2001 Jun; 382(6):891-902. PubMed ID: 11501753
[TBL] [Abstract][Full Text] [Related]
11. Role of TSG101 in uterine cervix cancer.
O'Boyle JD; Proctor ML; Fong KM; Lin WM; Miller DS; Muller CY
Gynecol Oncol; 1999 Dec; 75(3):401-5. PubMed ID: 10600297
[TBL] [Abstract][Full Text] [Related]
12. Structure and functional interactions of the Tsg101 UEV domain.
Pornillos O; Alam SL; Rich RL; Myszka DG; Davis DR; Sundquist WI
EMBO J; 2002 May; 21(10):2397-406. PubMed ID: 12006492
[TBL] [Abstract][Full Text] [Related]
13. TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation.
Lu Q; Hope LW; Brasch M; Reinhard C; Cohen SN
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7626-31. PubMed ID: 12802020
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of tumor susceptibility gene TSG101 in human papillary thyroid carcinomas.
Liu RT; Huang CC; You HL; Chou FF; Hu CC; Chao FP; Chen CM; Cheng JT
Oncogene; 2002 Jul; 21(31):4830-7. PubMed ID: 12101421
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
Shipley JM; Waxman DJ
Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
[TBL] [Abstract][Full Text] [Related]
16. Identification of cellular TSG101 protein in multiple human breast cancer cell lines.
Zhong Q; Chen CF; Chen Y; Chen PL; Lee WH
Cancer Res; 1997 Oct; 57(19):4225-8. PubMed ID: 9331081
[TBL] [Abstract][Full Text] [Related]
17. N-terminal transcriptional activation domain of LZIP comprises two LxxLL motifs and the host cell factor-1 binding motif.
Luciano RL; Wilson AC
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10757-62. PubMed ID: 10984507
[TBL] [Abstract][Full Text] [Related]
18. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
19. Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers.
Turpin E; Dalle B; de Roquancourt A; Plassa LF; Marty M; Janin A; Beuzard Y; de Thé H
Oncogene; 1999 Dec; 18(54):7834-7. PubMed ID: 10618725
[TBL] [Abstract][Full Text] [Related]
20. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
